ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Su‐xia Han

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1513-7427. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2018: 2 papers

Papers 2

High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/cam4.1833 ↗
Transcriptome-wide association study identifies multiple genes and pathways associated with pancreatic cancer. Last author DOI 10.1002/cam4.1836 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Liuyun Gong · 1 shared paper, 2018 · strength 0.10
- Paper Transcriptome-wide association study identifies multiple genes and pathways associated with pancreatic cancer. DOI 10.1002/cam4.1836 ↗
Congya Zhou · 1 shared paper, 2018 · strength 0.08
- Paper High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.1833 ↗
Xin Sui · 1 shared paper, 2018 · strength 0.08
- Paper High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.1833 ↗
Qing Zhu · 1 shared paper, 2018 · strength 0.08
- Paper High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. DOI 10.1002/cam4.1833 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.